Scope Of Issued Patents May Be Limited By Prosecution Estoppel Created In Child Cases - Patent

Cell therapy products in the U.S. are estimated to be worth approximately $4.5 billion currently and expected to grow to over $30 billion in the next ten years.

Related Keywords

California ,United States , ,Whitehead Institute ,Fate Therapeutics ,Shoreline Biosciences ,Prosecution History ,While Fate ,Prosecution History Estoppel ,History Estoppel ,Federal Circuit ,Mondaq ,Intellectual Property ,Life Sciences ,Patent Claims ,Patent Infringement ,Patent Law ,Patent Litigation ,Roskauer In Life Sciences ,Patent ,